These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8040751)

  • 21. The active compounds derived from Psoralea corylifolia for photochemotherapy against psoriasis-like lesions: The relationship between structure and percutaneous absorption.
    Alalaiwe A; Hung CF; Leu YL; Tahara K; Chen HH; Hu KY; Fang JY
    Eur J Pharm Sci; 2018 Nov; 124():114-126. PubMed ID: 30153523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of methotrexate and betamethasone with experimental phototoxic inflammation to PUVA (Psoralen and UVA) in mice.
    Ljunggren B; Möller H
    Arch Dermatol Res; 1979 Mar; 264(2):257-60. PubMed ID: 464643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The application of antioxidants in investigations and optimization of photochemotherapy.
    Potapenko AY; Kyagova AA
    Membr Cell Biol; 1998; 12(2):269-78. PubMed ID: 9879549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histologic observations of the lenses of psoralen + UVA treated albino rats and a theory as to the underlying mechanism.
    Jose JG; Koch HR; Respondek A
    Graefes Arch Clin Exp Ophthalmol; 1982; 219(1):44-53. PubMed ID: 7117861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psoralen photochemistry.
    Parsons BJ
    Photochem Photobiol; 1980 Dec; 32(6):813-21. PubMed ID: 7005917
    [No Abstract]   [Full Text] [Related]  

  • 26. Biopharmaceutics, pharmacokinetics and pharmacology of psoralens.
    Stolk LM; Siddiqui AH
    Gen Pharmacol; 1988; 19(5):649-53. PubMed ID: 3063592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psoralen-protein photochemistry--a forgotten field.
    Schmitt IM; Chimenti S; Gasparro FP
    J Photochem Photobiol B; 1995 Feb; 27(2):101-7. PubMed ID: 7714670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phospholipid methylation and membrane function.
    Axelrod J; Hirata F
    Ann N Y Acad Sci; 1981; 373():51-3. PubMed ID: 6951431
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhibition of restriction enzyme's DNA sequence recognition by PUVA treatment.
    Hanawa F; Okamoto M; Towers GH
    Photochem Photobiol; 2001 Aug; 74(2):269-73. PubMed ID: 11547565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of PUVA on expression of Fas and FasL in inducing apoptosis of NB4 and K562 cells].
    Chen NN; Zhang GY; Xiang Y; Zhang L; Zhang DJ; Huang SL
    Zhong Yao Cai; 2009 Jan; 32(1):78-82. PubMed ID: 19445127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of DNA-psoralen photoadducts in mammalian skin.
    Pathak MA; Zarebska Z; Mihm MC; Jarzabek-Chorzelska M; Chorzelski T; Jablonska S
    J Invest Dermatol; 1986 Mar; 86(3):308-15. PubMed ID: 2427607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Present aspects concerning the molecular mechanisms of photochemotherapy with psoralens.
    Rodighiero G; Dall'Acqua F
    Drugs Exp Clin Res; 1986; 12(6-7):507-15. PubMed ID: 3527629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local suppression of contact hypersensitivity in mice by a new bifunctional psoralen, 4,4',5'-trimethylazapsoralen, and UVA radiation.
    Aubin F; Dall'Acqua F; Kripke ML
    J Invest Dermatol; 1991 Jul; 97(1):50-4. PubMed ID: 2056193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psoralen photochemotherapy for vitiligo.
    Grimes PE
    Clin Dermatol; 1997; 15(6):921-6. PubMed ID: 9404695
    [No Abstract]   [Full Text] [Related]  

  • 35. Psoralenamines. 3. Synthesis, pharmacological behavior, and DNA binding of 5-(aminomethyl)-8-methoxy-, 5-[[(3-aminopropyl)oxy]methyl]-, and 8-[(3-aminopropyl)oxy]psoralen derivatives.
    Hansen JB; Bjerring P; Buchardt O; Ebbesen P; Kanstrup A; Karup G; Knudsen PH; Nielsen PE; Nordén B; Ygge B
    J Med Chem; 1985 Aug; 28(8):1001-10. PubMed ID: 4020822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of PUVA therapy on skin surface lipids: skin surface lipid peroxidation in psoriasis vulgaris and its biological significance.
    Hayakawa K; Matsuo I
    Tokai J Exp Clin Med; 1986 Nov; 11(5):317-22. PubMed ID: 3672560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PUVA therapy damages psoriatic and normal lymphoid cells within milliseconds.
    Böhm F; Meffert H; Bauer E
    Arch Dermatol Res; 1986; 279(1):16-9. PubMed ID: 3813650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Photoreactivity of furocoumarins and DNA in PUVA therapy: formation of psoralen-thymine adducts.
    Serrano-Pérez JJ; Merchán M; Serrano-Andrés L
    J Phys Chem B; 2008 Nov; 112(44):14002-10. PubMed ID: 18855465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The combination of oral and topical psoralen with UVA.
    Lobel E; Le Guay JL; King RH; Poyzer KG; Paver K
    Australas J Dermatol; 1980 Dec; 21(3):162-8. PubMed ID: 7236157
    [No Abstract]   [Full Text] [Related]  

  • 40. Risk of melanoma with psoralen/ultraviolet A therapy for psoriasis. Do the known risks now outweigh the benefits?
    Lindelöf B
    Drug Saf; 1999 Apr; 20(4):289-97. PubMed ID: 10230579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.